MedTrace Logo

31P Magnetic Resonance Spectroscopy Fructose Study

NCT02217605 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2014-08-15

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of an oral fructose challenge on liver adenosine triphosphate (ATP) reserves using 31P magnetic resonance spectroscopy (MRS) as a potential measure measure of liver health.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Fructose

Oral Fructose Challenge (75 g fructose in 500 ml water) following overnight fast

Sponsors & Collaborators

  • Biotechnology and Biological Sciences Research Council

    collaborator OTHER

  • Unilever R&D

    collaborator INDUSTRY

  • Stephen Bawden

    lead OTHER

Principal Investigators

  • Luca Marciani · University of Nottingham

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-09-30
Completion
2013-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02217605 on ClinicalTrials.gov